Back

Antibody against apolipoprotein-A1, Metabolic-Associated Fatty Liver Disease and cardiovascular risk: a translational study

26 August 2023 (15:15 - 15:50)
Organised by: Logo
Congress Presentation Part of: Vascular disease and perturbed lipid metabolism Lipids, Metabolism ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Sabrina Pagano

University hospitals of Geneva, Geneva (Switzerland)

6 More presentations in this session

Presentation thumbnail
Kallstatin/Serpina3c improves hyperlipidemia induced by high-fat diet via regulating glycolipid metabolism in adipose tissue
Miss J. Guo (Nanjing, CN)
Abstract Slides Video
Presentation thumbnail
Genetic Deletion of Hepatic NCOR1 regulates the bile acid metabolism and leads to reduction in atherosclerosis
Doctor S. Mohammed (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
Proteomic characterization of peripheral leukocytes in variant carriers of CDKAL1 associated with cholesterol efflux capacity
Doctor S. Lee (Seoul, KR)
Abstract Slides
Presentation thumbnail
Bile acids promote endothelial cell homeostasis via the regulation of cell metabolism and quiescence
Miss E. Dietrich (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
Cholesterol crystals as the main trigger of interleukin-6 production through innate inflammation in human spontaneously ruptured aortic plaques
Doctor S. Komatsu (Osaka, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Vascular disease and perturbed lipid metabolism

The Event

Event poster

ESC Congress 2023

26 August 2023 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Linking antibody against apolipoprotein A-1 to metabolic dysfunction-associated steatohepatitis in mice
thumbnail
Congress Presentation
Incremental prognostic value of metabolic dysfunction-associated fatty liver disease over coronary computed tomography angiography findings in patients with suspected coronary artery disease
thumbnail
Congress Session
Liver and lipids in cardiometabolic syndrome

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources